Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yun-Ju Kwon"'
Autor:
Jung Woong Yoon, Myoung Ok Kim, Sangsu Shin, Woo-Sung Kwon, Soo Hyun Kim, Yun-Ju Kwon, Sang In Lee
Publikováno v:
Toxics, Vol 12, Iss 7, p 487 (2024)
Antimicrobial peptides (AMPs) function to extensively suppress various problematic factors and are considered a new alternative for improving livestock health and enhancing immunomodulation. In this study, we explored whether AMP regulation has posit
Externí odkaz:
https://doaj.org/article/3d25c2a5494d475ea92e70c8b2287ff4
Publikováno v:
Journal of Apiculture. 34:125-129
Autor:
Ye-eun Jang, Jenita Immanuel, Jin-ri Lee, Yu-jin Jang, Yun Ju Kwon, Hyun Sook Kwon, Jung-Woog Shin, Sanguk Yun
Publikováno v:
Journal of Lipid and Atherosclerosis. 11:272
The endothelial inflammatory response plays an important role in atherogenesis by inducing nuclear factor (NF)κB-dependent cell adhesion molecule expression and monocyte recruitment. Here, we screened for natural ligands and investigated the ability
Machilin A Inhibits Tumor Growth and Macrophage M2 Polarization Through the Reduction of Lactic Acid
Autor:
Tae-Wook Chung, Eun-Yeong Kim, Chang Woo Han, So Young Park, Mi Suk Jeong, Dahye Yoon, Hee-Jung Choi, Ling Jin, Mi-Ju Park, Yun Ju Kwon, Hanna Lee, Keuk-Jun Kim, Kang Hyun Park, Suhkmann Kim, Se Bok Jang, Ki-Tae Ha
Publikováno v:
Cancers
Cancers, Vol 11, Iss 7, p 963 (2019)
Volume 11
Issue 7
Cancers, Vol 11, Iss 7, p 963 (2019)
Volume 11
Issue 7
Lactate dehydrogenase A (LDHA) is an important enzyme responsible for cancer growth and energy metabolism in various cancers via the aerobic glycolytic pathway. Here, we report that machilin A (MA), which acts as a competitive inhibitor by blocking t
Publikováno v:
Biological and Pharmaceutical Bulletin. 37:1406-1410
Dihydrofolate reductase (DHFR) has been confirmed to be a novel target for antibacterial drug development. In this study, we determined that a fungal metabolite from Stachybotrys sp. FN298 can inhibit the DHFR of Staphylococcus aureus. Its structure
Publikováno v:
Journal of Microbiology and Biotechnology. 23:184-188
In the continued search for inhibitors of enoyl-acyl carrier protein (ACP) reductase, we found that four acylbenzenediol sulfate metabolites from Streptomyces sp. AN1761 potently inhibited bacterial enoyl-ACP reductases of Staphylococcus aureus, Stre
Autor:
Heung-Mook Shin, Seung Tack Oh, Dong-Il Kim, Seongmi Lee, Yura Choi, Ha Jin Jeong, Jae-Hyun Han, Yun Ju Kwon, Hanna Lee, Songhee Jeon
Publikováno v:
Phytomedicine : international journal of phytotherapy and phytopharmacology. 24
Background Despite the benefits from different options of therapy for breast cancer, resistance of the disease to these therapies is rising and a novel agent is needed. Erythro-austrobailignan-6 (EA6) exhibits anti-cancer activity. However, the detai
Publikováno v:
Journal of Natural Products. 75:271-274
Flavimycins A (1) and B (2), novel dimeric 1,3-dihydroisobenzofurans, were isolated as inhibitors of peptide deformylase from cultures of Aspergillus flavipes. Their chemical structures were established by NMR and MS data analysis. Compounds 1 and 2
Publikováno v:
Bioscience, Biotechnology, and Biochemistry. 74:390-393
Two highly hydroxylated 1,3-dihydroisobenzofurans, FR198248 (1) and FR202306 (2), were isolated as peptide deformylase (PDF) inhibitors from Aspergillus flavipes. Compounds 1 and 2 inhibited Staphylococus aureus PDF with IC(50) values of 3.6 and 2.5
Publikováno v:
Biological and Pharmaceutical Bulletin. 32:2061-2064
Bacterial enoyl-acyl carrier protein (ACP) reductase has been confirmed as a novel target for antibacterial drug development. In this study, we determined that a fungal metabolite from Sporothrix sp. FN611 potently inhibited the enoyl-ACP reductase (